RARE ULTRAGENYX PHARMACEUTICAL INC Management Changes 8-K Filing 2023 - Departure of Directors or Certain Officers Ultragenyx Pharmaceutical Inc. announced the departure of its Executive Vice President and Chief Medical Officer, Camille L. Bedrosian, who will transition to a new role as Strategic Development Advisor to the Company.Get access to all SEC 8-K filings of the ULTRAGENYX PHARMACEUTICAL INC